Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-02

FDA Approved: OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION — Original Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved the original application for olopatadine hydrochloride ophthalmic solution from Gland Pharma Limited, a generic treatment for allergic conjunctivit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (OLOPATADINE HYDROCHLORIDE OPHTHALMIC)